HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Taniguchi Selected Research

Neutralizing Antibodies

5/2023Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.
11/2021Embryonic Stage of Congenital Zika Virus Infection Determines Fetal and Postnatal Outcomes in Mice.
10/2021Genotype-Dependent Immunogenicity of Dengue Virus Type 2 Asian I and Asian/American Genotypes in Common Marmoset (Callithrix jacchus): Discrepancy in Neutralizing and Infection-Enhancing Antibody Levels between Genotypes.
9/2021Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV.
9/2018Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
1/2018Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus).
2/2017A case of consecutive infection with Zika virus and Chikungunya virus in Bora Bora, French Polynesia.
12/2014Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Taniguchi Research Topics

Disease

15Infections
12/2023 - 01/2014
12Severe Fever with Thrombocytopenia Syndrome
01/2021 - 01/2014
8Pulmonary Embolism
04/2020 - 03/2005
5Vesicular Stomatitis
10/2023 - 07/2014
4Virus Diseases (Viral Diseases)
10/2020 - 11/2015
3Stroke (Strokes)
05/2020 - 03/2005
3Aortic Dissection
01/2017 - 02/2009
2Dengue (Dengue Fever)
05/2023 - 01/2018
2Abdominal Aortic Aneurysm
02/2023 - 03/2017
2Japanese Encephalitis
09/2021 - 09/2018
2Hemorrhage
03/2019 - 01/2011
2Body Weight (Weight, Body)
01/2018 - 01/2016
2Shock
01/2018 - 03/2005
2Hypertension (High Blood Pressure)
02/2009 - 05/2004
2Hypothermia
12/2006 - 06/2002
1Fever (Fevers)
01/2024
1Type 2 Diabetes Mellitus (MODY)
01/2024
1Arenaviridae Infections
03/2023
1Aortic Aneurysm (Aneurysm, Aortic)
02/2023
1Ebola Hemorrhagic Fever
01/2022
1Perinatal Death
11/2021
1Viremia
10/2021
1Necrosis
01/2021
1Hyperuricemia
11/2020
1COVID-19
11/2020
1Human Influenza (Influenza)
11/2020
1Intracranial Embolism
04/2020
1Diabetic Angiopathies (Diabetic Angiopathy)
09/2019
1Sarcopenia
09/2019
1Dyspnea (Shortness of Breath)
02/2019
1Brain Hypoxia (Cerebral Hypoxia)
02/2019
1Hypoplastic Left Heart Syndrome
01/2019
1Mitral Valve Insufficiency (Mitral Regurgitation)
11/2018
1Myocardial Infarction
01/2018
1Obesity
01/2018
1Heart Failure
01/2018
1Chronic Obstructive Pulmonary Disease (COPD)
01/2018
1Respiratory Insufficiency (Respiratory Failure)
01/2018
1Cardiac Arrhythmias (Arrythmia)
01/2018
1Coma (Comas)
01/2018
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2018
1Congenitally Corrected Transposition of the Great Arteries
11/2017
1Persistent Left Superior Vena Cava
11/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2017
1Muscle Weakness
05/2017
1Intra-Abdominal Hypertension
03/2017
1Zika Virus Infection
02/2017
1Rickettsia Infections
01/2017
1False Aneurysm (Pseudoaneurysm)
01/2017
1Endoleak
01/2017
1Fetal Death
06/2016
1Maternal Death
06/2016

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
01/2024 - 12/2017
8Neutralizing AntibodiesIBA
05/2023 - 12/2014
6Glycoproteins (Glycoprotein)IBA
10/2023 - 12/2014
6AntibodiesIBA
05/2023 - 08/2006
4Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
12/2023 - 01/2016
4favipiravirIBA
01/2022 - 01/2016
4AntigensIBA
10/2021 - 09/2015
3Ribavirin (Virazole)FDA LinkGeneric
01/2022 - 01/2014
3Proteins (Proteins, Gene)FDA Link
05/2016 - 07/2014
2Antiviral Agents (Antivirals)IBA
10/2023 - 01/2021
2EnzymesIBA
05/2023 - 10/2021
2Immunoglobulin G (IgG)IBA
05/2023 - 12/2014
2Immunoglobulin M (IgM)IBA
05/2023 - 02/2017
2ImmunosorbentsIBA
05/2023 - 10/2021
2Advanced Glycation End ProductsIBA
09/2019 - 05/2017
2Amino AcidsFDA Link
01/2019 - 12/2006
2RestonIBA
01/2018 - 10/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2023
1RNA (Ribonucleic Acid)IBA
01/2022
1Viral AntigensIBA
01/2021
1Viral RNAIBA
11/2020
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
11/2020
1Protein Kinase InhibitorsIBA
10/2020
1Protein Kinases (Protein Kinase)IBA
10/2020
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2020
1IntegrinsIBA
01/2020
1LectinsIBA
01/2020
1Intercellular Adhesion Molecule-3IBA
01/2020
1CalciumIBA
01/2020
1Serine (L-Serine)FDA Link
01/2019
1Therapeutic UsesIBA
01/2018
1omega-Chloroacetophenone (Mace)IBA
01/2018
1C-Reactive ProteinIBA
01/2017

Therapy/Procedure

8Embolectomy
04/2020 - 03/2005
6Therapeutics
10/2023 - 02/2009
5Stents
03/2019 - 02/2009
3Endovascular Aneurysm Repair
02/2023 - 01/2017
2Oral Administration
01/2018 - 01/2016
1Glycemic Control
01/2024
1Thrombectomy
05/2020
1Tracheostomy
02/2019
1Norwood Procedures
01/2019
1Cardiac Valve Annuloplasty
11/2018
1Cardiopulmonary Resuscitation (CPR)
01/2018
1Arterial Switch Operation
11/2017
1Lower Body Negative Pressure
03/2017
1Endovascular Procedures
01/2017
1Cardiopulmonary Bypass (Heart-Lung Bypass)
06/2016